LAD Syndromes
. | LAD I* . | LAD II . |
---|---|---|
Clinical manifestations | ||
Recurrent severe infections | Frequent | Not observed |
Neutrophilia | ||
Basal | + | ++ |
With infections | +++ | ++ |
Periodontitis | Common | Marked |
Skin infections | Common | Not observed |
Delayed separation of the umbilical cord | Common | Not observed |
Developmental abnormalities | None | Marked |
Laboratory findings | ||
CD18 expression | Marked decrease or absent | Normal |
SLeX expression | Normal | Absent |
Neutrophil rolling | Normal | Marked decrease |
Neutrophil firm adherence | Marked decrease | Normal |
T- and B-cell function | Decreased | Normal |
. | LAD I* . | LAD II . |
---|---|---|
Clinical manifestations | ||
Recurrent severe infections | Frequent | Not observed |
Neutrophilia | ||
Basal | + | ++ |
With infections | +++ | ++ |
Periodontitis | Common | Marked |
Skin infections | Common | Not observed |
Delayed separation of the umbilical cord | Common | Not observed |
Developmental abnormalities | None | Marked |
Laboratory findings | ||
CD18 expression | Marked decrease or absent | Normal |
SLeX expression | Normal | Absent |
Neutrophil rolling | Normal | Marked decrease |
Neutrophil firm adherence | Marked decrease | Normal |
T- and B-cell function | Decreased | Normal |
Adapted and reprinted from Etzioni et al8in Ochs HD, Smith CIE, Puck JM (eds): Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York, NY, Oxford, 1999.
Severe phenotype.